Escherichia coli edible vaccine - ProdiGene

Drug Profile

Escherichia coli edible vaccine - ProdiGene

Alternative Names: ETEC edible vaccine - ProdiGene; Lt-B vaccine

Latest Information Update: 24 Apr 2007

Price : $50

At a glance

  • Originator ProdiGene
  • Class Escherichia coli vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Escherichia coli infections

Most Recent Events

  • 16 Aug 2002 Phase-I clinical trials in Escherichia coli infections in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top